ID   E2AK4_HUMAN             Reviewed;        1649 AA.
AC   Q9P2K8; C9JEC4; Q69YL7; Q6DC97; Q96GN6; Q9H5K1; Q9NSQ3; Q9NSZ5;
AC   Q9UJ56;
DT   15-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   15-MAR-2017, entry version 153.
DE   RecName: Full=eIF-2-alpha kinase GCN2 {ECO:0000250|UniProtKB:Q9QZ05};
DE            EC=2.7.11.1 {ECO:0000250|UniProtKB:Q9QZ05};
DE   AltName: Full=Eukaryotic translation initiation factor 2-alpha kinase 4 {ECO:0000312|HGNC:HGNC:19687};
DE   AltName: Full=GCN2-like protein;
GN   Name=EIF2AK4 {ECO:0000312|HGNC:HGNC:19687}; Synonyms=GCN2, KIAA1338;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 821-1649 (ISOFORM 1), AND VARIANT
RP   CYS-1306.
RC   TISSUE=Muscle, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 177-1649.
RC   TISSUE=Brain;
RX   PubMed=10718198; DOI=10.1093/dnares/7.1.65;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVI.
RT   The complete sequences of 150 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:65-73(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 196-1649, AND VARIANT
RP   LEU-441.
RC   TISSUE=Melanoma, and Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 831-1649.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1102-1649, AND TISSUE SPECIFICITY.
RX   PubMed=10504407; DOI=10.1046/j.1432-1327.1999.00780.x;
RA   Berlanga J.J., Santoyo J., de Haro C.;
RT   "Characterization of a mammalian homolog of the GCN2 eukaryotic
RT   initiation factor 2alpha kinase.";
RL   Eur. J. Biochem. 265:754-762(1999).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-667, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-230 AND THR-667, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-230, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-667, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-1259, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-230 AND THR-667, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-230, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-230; THR-667 AND
RP   THR-871, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   INVOLVEMENT IN PVOD2.
RX   PubMed=24135949; DOI=10.1378/chest.13-2366;
RA   Best D.H., Sumner K.L., Austin E.D., Chung W.K., Brown L.M.,
RA   Borczuk A.C., Rosenzweig E.B., Bayrak-Toydemir P., Mao R.,
RA   Cahill B.C., Tazelaar H.D., Leslie K.O., Hemnes A.R., Robbins I.M.,
RA   Elliott C.G.;
RT   "EIF2AK4 mutations in pulmonary capillary hemangiomatosis.";
RL   Chest 145:231-236(2014).
RN   [17]
RP   TISSUE SPECIFICITY, AND VARIANTS PVOD2 GLN-585 AND ARG-643.
RX   PubMed=24292273; DOI=10.1038/ng.2844;
RA   Eyries M., Montani D., Girerd B., Perret C., Leroy A., Lonjou C.,
RA   Chelghoum N., Coulet F., Bonnet D., Dorfmueller P., Fadel E.,
RA   Sitbon O., Simonneau G., Tregouet D.A., Humbert M., Soubrier F.;
RT   "EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive
RT   form of pulmonary hypertension.";
RL   Nat. Genet. 46:65-69(2014).
RN   [18]
RP   FUNCTION (MICROBIAL INFECTION).
RX   PubMed=24310610; DOI=10.1126/science.1246829;
RA   Ravindran R., Khan N., Nakaya H.I., Li S., Loebbermann J.,
RA   Maddur M.S., Park Y., Jones D.P., Chappert P., Davoust J., Weiss D.S.,
RA   Virgin H.W., Ron D., Pulendran B.;
RT   "Vaccine activation of the nutrient sensor GCN2 in dendritic cells
RT   enhances antigen presentation.";
RL   Science 343:313-317(2014).
RN   [19]
RP   FUNCTION.
RX   PubMed=25329545; DOI=10.1042/BJ20140852;
RA   Roobol A., Roobol J., Bastide A., Knight J.R., Willis A.E.,
RA   Smales C.M.;
RT   "p58IPK is an inhibitor of the eIF2alpha kinase GCN2 and its
RT   localization and expression underpin protein synthesis and ER
RT   processing capacity.";
RL   Biochem. J. 465:213-225(2015).
RN   [20]
RP   FUNCTION.
RX   PubMed=26102367; DOI=10.1371/journal.pgen.1005212;
RA   Lehman S.L., Cerniglia G.J., Johannes G.J., Ye J., Ryeom S.,
RA   Koumenis C.;
RT   "Translational Upregulation of an Individual p21Cip1 Transcript
RT   Variant by GCN2 Regulates Cell Proliferation and Survival under
RT   Nutrient Stress.";
RL   PLoS Genet. 11:E1005212-E1005212(2015).
RN   [21]
RP   VARIANTS [LARGE SCALE ANALYSIS] ARG-137; TRP-166; LEU-441; VAL-872;
RP   TYR-939; ARG-1060; CYS-1306; ARG-1336 AND HIS-1406.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Metabolic-stress sensing protein kinase that
CC       phosphorylates the alpha subunit of eukaryotic translation
CC       initiation factor 2 (eIF-2-alpha/EIF2S1) on 'Ser-52' in response
CC       to low amino acid availability (PubMed:25329545). Plays a role as
CC       an activator of the integrated stress response (ISR) required for
CC       adapatation to amino acid starvation. Converts phosphorylated eIF-
CC       2-alpha/EIF2S1 either to a competitive inhibitor of the
CC       translation initiation factor eIF-2B, leading to a global protein
CC       synthesis repression, and thus to a reduced overall utilization of
CC       amino acids, or to a translational initiation activation of
CC       specific mRNAs, such as the transcriptional activator ATF4, and
CC       hence allowing ATF4-mediated reprogramming of amino acid
CC       biosynthetic gene expression to alleviate nutrient depletion.
CC       Binds uncharged tRNAs (By similarity). Involved in cell cycle
CC       arrest by promoting cyclin D1 mRNA translation repression after
CC       the unfolded protein response pathway (UPR) activation or cell
CC       cycle inhibitor CDKN1A/p21 mRNA translation activation in response
CC       to amino acid deprivation (PubMed:26102367). Plays a role in the
CC       consolidation of synaptic plasticity, learning as well as
CC       formation of long-term memory. Plays a role in neurite outgrowth
CC       inhibition. Plays a proapoptotic role in response to glucose
CC       deprivation. Promotes global cellular protein synthesis repression
CC       in response to UV irradiation independently of the stress-
CC       activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) and
CC       p38 MAPK signaling pathways (By similarity). Plays a role in the
CC       antiviral response against alphavirus infection; impairs early
CC       viral mRNA translation of the incoming genomic virus RNA, thus
CC       preventing alphavirus replication (By similarity).
CC       {ECO:0000250|UniProtKB:P15442, ECO:0000250|UniProtKB:Q9QZ05,
CC       ECO:0000269|PubMed:25329545, ECO:0000269|PubMed:26102367}.
CC   -!- FUNCTION: (Microbial infection) Plays a role in modulating the
CC       adaptive immune response to yellow fever virus infection; promotes
CC       dendritic cells to initiate autophagy and antigene presentation to
CC       both CD4(+) and CD8(+) T-cells under amino acid starvation
CC       (PubMed:24310610). {ECO:0000269|PubMed:24310610}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000250|UniProtKB:Q9QZ05}.
CC   -!- SUBUNIT: Homodimer; homodimerization is important for kinase
CC       activation by uncharged tRNAs. Interacts with GCN1; this
CC       interaction stimulates EIF2AK4/GCN2 kinase activity and is
CC       impaired by IMPACT upon a variety of stress conditions, such as
CC       amino acid depletion, UV-C irradiation, proteasome inhibitor
CC       treatment and glucose deprivation. Interacts with DNAJC3; this
CC       interaction inhibits EIF2AK4/GCN2 kinase activity during
CC       endoplasmic reticulum (ER), hypothermic and amino acid-starving
CC       stress conditions. {ECO:0000250|UniProtKB:P15442,
CC       ECO:0000250|UniProtKB:Q9QZ05}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9QZ05}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9P2K8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9P2K8-2; Sequence=VSP_013038;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q9P2K8-3; Sequence=VSP_039185, VSP_039186;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed (PubMed:10504407). Expressed
CC       in lung, smooth muscle cells and macrophages (PubMed:24292273).
CC       {ECO:0000269|PubMed:10504407, ECO:0000269|PubMed:24292273}.
CC   -!- DOMAIN: The histidyl-tRNA synthetase-like region and protein
CC       kinase domains are necessary for eIF-2-alpha kinase activity and
CC       eIF-2-alpha-mediated translational control. The histidyl-tRNA
CC       synthetase-like domain is necessary for binding to uncharged
CC       tRNAs. Kinase domain 1 is a degenerate kinase domain.
CC       {ECO:0000250|UniProtKB:Q9QZ05}.
CC   -!- PTM: Autophosphorylated; autophosphorylation on Thr-899 is
CC       increased upon amino acid starvation and in UV irradiation cells
CC       and inhibited in presence of IMPACT.
CC       {ECO:0000250|UniProtKB:Q9QZ05}.
CC   -!- DISEASE: Pulmonary venoocclusive disease 2, autosomal recessive
CC       (PVOD2) [MIM:234810]: A disease characterized by widespread
CC       fibrous obstruction and intimal thickening of septal veins and
CC       preseptal venules, a low diffusing capacity for carbon monoxide,
CC       occult alveolar hemorrhage, and nodular ground-glass opacities,
CC       septal lines and lymph node enlargement showed by high-resolution
CC       computed tomography of the chest. It is frequently associated with
CC       pulmonary capillary dilatation and proliferation, and is a rare
CC       and devastating cause of pulmonary hypertension.
CC       {ECO:0000269|PubMed:24135949, ECO:0000269|PubMed:24292273}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family. GCN2 subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA92576.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Sequence of unknown origin in the N-terminal part.; Evidence={ECO:0000305};
CC       Sequence=BAB15625.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC012377; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC025168; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC009350; AAH09350.2; -; mRNA.
DR   EMBL; BC078179; AAH78179.1; -; mRNA.
DR   EMBL; AB037759; BAA92576.1; ALT_SEQ; mRNA.
DR   EMBL; AL137627; CAB70849.1; -; mRNA.
DR   EMBL; AL157497; CAB75678.1; -; mRNA.
DR   EMBL; AL832907; CAH10626.1; -; mRNA.
DR   EMBL; AK027011; BAB15625.1; ALT_INIT; mRNA.
DR   EMBL; AJ243428; CAB58360.1; -; mRNA.
DR   CCDS; CCDS42016.1; -. [Q9P2K8-1]
DR   PIR; T46924; T46924.
DR   RefSeq; NP_001013725.2; NM_001013703.3. [Q9P2K8-1]
DR   UniGene; Hs.656673; -.
DR   ProteinModelPortal; Q9P2K8; -.
DR   BioGrid; 136426; 20.
DR   IntAct; Q9P2K8; 20.
DR   STRING; 9606.ENSP00000263791; -.
DR   BindingDB; Q9P2K8; -.
DR   ChEMBL; CHEMBL5358; -.
DR   GuidetoPHARMACOLOGY; 2018; -.
DR   iPTMnet; Q9P2K8; -.
DR   PhosphoSitePlus; Q9P2K8; -.
DR   BioMuta; EIF2AK4; -.
DR   DMDM; 296439368; -.
DR   EPD; Q9P2K8; -.
DR   MaxQB; Q9P2K8; -.
DR   PaxDb; Q9P2K8; -.
DR   PeptideAtlas; Q9P2K8; -.
DR   PRIDE; Q9P2K8; -.
DR   DNASU; 440275; -.
DR   Ensembl; ENST00000263791; ENSP00000263791; ENSG00000128829. [Q9P2K8-1]
DR   Ensembl; ENST00000559624; ENSP00000453148; ENSG00000128829. [Q9P2K8-3]
DR   GeneID; 440275; -.
DR   KEGG; hsa:440275; -.
DR   UCSC; uc001zkl.4; human. [Q9P2K8-1]
DR   CTD; 440275; -.
DR   DisGeNET; 440275; -.
DR   GeneCards; EIF2AK4; -.
DR   H-InvDB; HIX0012119; -.
DR   HGNC; HGNC:19687; EIF2AK4.
DR   HPA; HPA011811; -.
DR   MalaCards; EIF2AK4; -.
DR   MIM; 234810; phenotype.
DR   MIM; 609280; gene.
DR   neXtProt; NX_Q9P2K8; -.
DR   OpenTargets; ENSG00000128829; -.
DR   Orphanet; 199241; Pulmonary capillary hemangiomatosis.
DR   Orphanet; 31837; Pulmonary venoocclusive disease.
DR   PharmGKB; PA134947616; -.
DR   eggNOG; KOG1035; Eukaryota.
DR   eggNOG; COG0124; LUCA.
DR   GeneTree; ENSGT00530000062984; -.
DR   HOVERGEN; HBG051432; -.
DR   InParanoid; Q9P2K8; -.
DR   KO; K16196; -.
DR   OMA; KCVCLDD; -.
DR   OrthoDB; EOG091G0NNL; -.
DR   PhylomeDB; Q9P2K8; -.
DR   TreeFam; TF101512; -.
DR   SignaLink; Q9P2K8; -.
DR   SIGNOR; Q9P2K8; -.
DR   ChiTaRS; EIF2AK4; human.
DR   GeneWiki; EIF2AK4; -.
DR   GenomeRNAi; 440275; -.
DR   PRO; PR:Q9P2K8; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000128829; -.
DR   CleanEx; HS_EIF2AK4; -.
DR   ExpressionAtlas; Q9P2K8; baseline and differential.
DR   Genevisible; Q9P2K8; HS.
DR   GO; GO:0022626; C:cytosolic ribosome; ISS:UniProtKB.
DR   GO; GO:0005844; C:polysome; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004694; F:eukaryotic translation initiation factor 2alpha kinase activity; IMP:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0000049; F:tRNA binding; ISS:UniProtKB.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0007050; P:cell cycle arrest; IEA:UniProtKB-KW.
DR   GO; GO:0034198; P:cellular response to amino acid starvation; IMP:UniProtKB.
DR   GO; GO:0070417; P:cellular response to cold; IMP:UniProtKB.
DR   GO; GO:1990253; P:cellular response to leucine starvation; ISS:UniProtKB.
DR   GO; GO:0034644; P:cellular response to UV; ISS:UniProtKB.
DR   GO; GO:0051607; P:defense response to virus; IEA:UniProtKB-KW.
DR   GO; GO:0036492; P:eiF2alpha phosphorylation in response to endoplasmic reticulum stress; IMP:UniProtKB.
DR   GO; GO:0039520; P:induction by virus of host autophagy; ISS:UniProtKB.
DR   GO; GO:0007612; P:learning; ISS:UniProtKB.
DR   GO; GO:0007616; P:long-term memory; ISS:UniProtKB.
DR   GO; GO:0044828; P:negative regulation by host of viral genome replication; ISS:UniProtKB.
DR   GO; GO:0032792; P:negative regulation of CREB transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0045947; P:negative regulation of translational initiation; ISS:UniProtKB.
DR   GO; GO:0032057; P:negative regulation of translational initiation in response to stress; ISS:UniProtKB.
DR   GO; GO:1990138; P:neuron projection extension; ISS:UniProtKB.
DR   GO; GO:0002821; P:positive regulation of adaptive immune response; ISS:UniProtKB.
DR   GO; GO:0002230; P:positive regulation of defense response to virus by host; ISS:UniProtKB.
DR   GO; GO:1900273; P:positive regulation of long-term synaptic potentiation; ISS:UniProtKB.
DR   GO; GO:0071264; P:positive regulation of translational initiation in response to starvation; ISS:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; ISS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:0060733; P:regulation of eIF2 alpha phosphorylation by amino acid starvation; IMP:UniProtKB.
DR   GO; GO:0060259; P:regulation of feeding behavior; ISS:UniProtKB.
DR   GO; GO:0006446; P:regulation of translational initiation; ISS:UniProtKB.
DR   GO; GO:0010998; P:regulation of translational initiation by eIF2 alpha phosphorylation; IMP:UniProtKB.
DR   GO; GO:0002286; P:T cell activation involved in immune response; ISS:UniProtKB.
DR   GO; GO:0019081; P:viral translation; ISS:UniProtKB.
DR   Gene3D; 3.10.110.10; -; 1.
DR   Gene3D; 3.40.50.800; -; 1.
DR   InterPro; IPR004154; Anticodon-bd.
DR   InterPro; IPR024435; HisRS-related_dom.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR006575; RWD-domain.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR016135; UBQ-conjugating_enzyme/RWD.
DR   Pfam; PF12745; HGTP_anticodon2; 1.
DR   Pfam; PF00069; Pkinase; 3.
DR   Pfam; PF05773; RWD; 1.
DR   SMART; SM00591; RWD; 1.
DR   SMART; SM00220; S_TKc; 2.
DR   SUPFAM; SSF54495; SSF54495; 1.
DR   SUPFAM; SSF56112; SSF56112; 3.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 2.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50908; RWD; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Activation of host autophagy by virus; Activator;
KW   Adaptive immunity; Alternative splicing; Antiviral defense;
KW   ATP-binding; Cell cycle; Coiled coil; Complete proteome; Cytoplasm;
KW   Disease mutation; Growth arrest; Host-virus interaction; Immunity;
KW   Kinase; Neurogenesis; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat; RNA-binding;
KW   Serine/threonine-protein kinase; Stress response; Transferase;
KW   Translation regulation; tRNA-binding.
FT   CHAIN         1   1649       eIF-2-alpha kinase GCN2.
FT                                /FTId=PRO_0000085947.
FT   DOMAIN       25    137       RWD. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00179}.
FT   DOMAIN      296    539       Protein kinase 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      590   1001       Protein kinase 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     596    604       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REGION     1022   1493       Histidyl-tRNA synthetase-like.
FT   COILED      146    205       {ECO:0000255}.
FT   COMPBIAS    484    491       Poly-Leu.
FT   ACT_SITE    848    848       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     619    619       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     230    230       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     667    667       Phosphothreonine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     871    871       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     899    899       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000250|UniProtKB:Q9QZ05}.
FT   MOD_RES     904    904       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000250}.
FT   MOD_RES    1259   1259       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VAR_SEQ     608    616       QNKLDGCCY -> WYRVIPSPL (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_039185.
FT   VAR_SEQ     617   1649       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_039186.
FT   VAR_SEQ     774    801       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_013038.
FT   VARIANT     137    137       H -> R (in dbSNP:rs35509999).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040479.
FT   VARIANT     166    166       R -> W (in dbSNP:rs34439704).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040480.
FT   VARIANT     441    441       I -> L (in dbSNP:rs2291627).
FT                                {ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|PubMed:17974005}.
FT                                /FTId=VAR_040481.
FT   VARIANT     585    585       R -> Q (in PVOD2; dbSNP:rs587777106).
FT                                {ECO:0000269|PubMed:24292273}.
FT                                /FTId=VAR_070990.
FT   VARIANT     643    643       L -> R (in PVOD2; dbSNP:rs757852728).
FT                                {ECO:0000269|PubMed:24292273}.
FT                                /FTId=VAR_070991.
FT   VARIANT     872    872       D -> V (in dbSNP:rs34665481).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040482.
FT   VARIANT     939    939       H -> Y (in a lung neuroendocrine
FT                                carcinoma sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040483.
FT   VARIANT    1060   1060       T -> R (in dbSNP:rs55781333).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040484.
FT   VARIANT    1306   1306       G -> C (in dbSNP:rs35602605).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040485.
FT   VARIANT    1336   1336       K -> R (in dbSNP:rs35480871).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040486.
FT   VARIANT    1406   1406       Q -> H (in dbSNP:rs55721315).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040487.
FT   CONFLICT    556    556       E -> G (in Ref. 3; BAA92576 and 4;
FT                                CAH10626). {ECO:0000305}.
FT   CONFLICT    629    629       Q -> K (in Ref. 4; CAH10626).
FT                                {ECO:0000305}.
FT   CONFLICT    858    858       S -> F (in Ref. 5; BAB15625).
FT                                {ECO:0000305}.
FT   CONFLICT   1133   1133       N -> I (in Ref. 6; CAB58360).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1649 AA;  186911 MW;  ECF3CFFA51AEE67C CRC64;
     MAGGRGAPGR GRDEPPESYP QRQDHELQAL EAIYGADFQD LRPDACGPVK EPPEINLVLY
     PQGLTGEEVY VKVDLRVKCP PTYPDVVPEI ELKNAKGLSN ESVNLLKSRL EELAKKHCGE
     VMIFELAYHV QSFLSEHNKP PPKSFHEEML ERRAQEEQQR LLEAKRKEEQ EQREILHEIQ
     RRKEEIKEEK KRKEMAKQER LEIASLSNQD HTSKKDPGGH RTAAILHGGS PDFVGNGKHR
     ANSSGRSRRE RQYSVCNSED SPGSCEILYF NMGSPDQLMV HKGKCIGSDE QLGKLVYNAL
     ETATGGFVLL YEWVLQWQKK MGPFLTSQEK EKIDKCKKQI QGTETEFNSL VKLSHPNVVR
     YLAMNLKEQD DSIVVDILVE HISGVSLAAH LSHSGPIPVH QLRRYTAQLL SGLDYLHSNS
     VVHKVLSASN VLVDAEGTVK ITDYSISKRL ADICKEDVFE QTRVRFSDNA LPYKTGKKGD
     VWRLGLLLLS LSQGQECGEY PVTIPSDLPA DFQDFLKKCV CLDDKERWSP QQLLKHSFIN
     PQPKMPLVEQ SPEDSEGQDY VETVIPSNRL PSAAFFSETQ RQFSRYFIEF EELQLLGKGA
     FGAVIKVQNK LDGCCYAVKR IPINPASRQF RRIKGEVTLL SRLHHENIVR YYNAWIERHE
     RPAGPGTPPP DSGPLAKDDR AARGQPASDT DGLDSVEAAA PPPILSSSVE WSTSGERSAS
     ARFPATGPGS SDDEDDDEDE HGGVFSQSFL PASDSESDII FDNEDENSKS QNQDEDCNEK
     NGCHESEPSV TTEAVHYLYI QMEYCEKSTL RDTIDQGLYR DTVRLWRLFR EILDGLAYIH
     EKGMIHRDLK PVNIFLDSDD HVKIGDFGLA TDHLAFSADS KQDDQTGDLI KSDPSGHLTG
     MVGTALYVSP EVQGSTKSAY NQKVDLFSLG IIFFEMSYHP MVTASERIFV LNQLRDPTSP
     KFPEDFDDGE HAKQKSVISW LLNHDPAKRP TATELLKSEL LPPPQMEESE LHEVLHHTLT
     NVDGKAYRTM MAQIFSQRIS PAIDYTYDSD ILKGNFSIRT AKMQQHVCET IIRIFKRHGA
     VQLCTPLLLP RNRQIYEHNE AALFMDHSGM LVMLPFDLRI PFARYVARNN ILNLKRYCIE
     RVFRPRKLDR FHPKELLECA FDIVTSTTNS FLPTAEIIYT IYEIIQEFPA LQERNYSIYL
     NHTMLLKAIL LHCGIPEDKL SQVYIILYDA VTEKLTRREV EAKFCNLSLS SNSLCRLYKF
     IEQKGDLQDL MPTINSLIKQ KTGIAQLVKY GLKDLEEVVG LLKKLGIKLQ VLINLGLVYK
     VQQHNGIIFQ FVAFIKRRQR AVPEILAAGG RYDLLIPQFR GPQALGPVPT AIGVSIAIDK
     ISAAVLNMEE SVTISSCDLL VVSVGQMSMS RAINLTQKLW TAGITAEIMY DWSQSQEELQ
     EYCRHHEITY VALVSDKEGS HVKVKSFEKE RQTEKRVLET ELVDHVLQKL RTKVTDERNG
     REASDNLAVQ NLKGSFSNAS GLFEIHGATV VPIVSVLAPE KLSASTRRRY ETQVQTRLQT
     SLANLHQKSS EIEILAVDLP KETILQFLSL EWDADEQAFN TTVKQLLSRL PKQRYLKLVC
     DEIYNIKVEK KVSVLFLYSY RDDYYRILF
//
